[Rx2021] SIO/SCCP New Drug Series: CAR-T Cell Therapy

[Rice, Mikhaila Lynn]

Hello,

As a continuation of the New Drug Series, Student Industry Organization (SIO) and Student College of Clinical Pharmacy (SCCP) present CAR-T Cell Therapy and its utilization in patients with B cell lymphoma.

Journal Club: Tuesday, October 3rd
Join us at noon in 402 for a Journal Club on CAR-T Cell Therapy led by Rachel Cartus (P3), one of our Fellows. If you have time to review the journal article prior to the journal club, please do so!

Accessible via HSLS/PubMed:
Locke FL, Neelapu SS, Bartlett NL, et. al. Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma. Mol Ther. 2017; 25(1): 285-95.

New Drug Series Lecture: Thursday Oct 12th
A representative from Kite Pharma will be coming in to talk more about CAR-T Cell Therapy.

For those of you interested in industry, this will be a great opportunity to see a unique role of a pharmacist in the field. For those interested in clinical pharmacy, this will provide you with foundational knowledge about a new and exciting therapy so that you can inform your health care team on rotations or in residency.

If you have any questions regarding the New Drug Series or Journal Club, please reach out to any leaders within SIO or SCCP. We look forward to seeing you there!

Sincerely,
SIO and SCCP Executive Boards
pitt.accp.eboard at gmail.com<mailto:pitt.accp.eboard at gmail.com>
studentindustryorg at gmail.com<mailto:studentindustryorg at gmail.com>
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://list.pitt.edu/pipermail/rx2021/attachments/20171001/44875e1c/attachment.html>